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Background: Gallbladder diseases present with cholelithiasis in a wide spectrum of adenomas and cancers. Two or
three specimens are sampled in cholecystectomies in routine pathology practice. The aim of this study was to
investigate the increase in frequency of histologic alterations in cholecystectomies, particularly precancerous lesions,
by increasing the sample size to understand the carcinoma pathway.
Methods: Cholecystectomies of 432 patients with pathology records and materials from two medical centers were
collected, and two groups were created. Initial data with two or three samples were allocated to Group 1 and the
new six samples with the initial ones were allocated to Group 2. Hematoxylin and eosin (H&E) sections were
examined for histopathologic alterations, and periodic acid–Schiff (PAS) Alcian blue (pH 2.5) and high iron
diamine (pH 2.5) stains were used to signify the mucin profile in case of metaplasias. For the comparison of
findings, non-parametric tests, McNemar’s tests, chi-squared tests and Fisher’s exact test were performed.
Results: Of the 432 patients, 308 (71.3%) patients were female and 124 (28.7%) patients were male. The mean
age of patients was 47.9 ± 14.6 years. Cholesterolosis was observed in 95 (22%) patients in Group 1 and 108
(25%) patients in Group 2. Gallstones were detected in 255 (59%) of the cholecystectomies. There was a
significant difference between Group 1 and Group 2 by increasing the sample size when we compared
cholesterolosis, metaplasia and polyps (P <0.05). Cholecystitis and dysplasia rates were the same in both of the
groups. There was no cancer determined.
Conclusion: Increasing the sample size in cholecystectomies increased the diagnosis of some histologic
alterations, but further studies with a larger number of samples over a longer period time might increase the
ability to determine precancerous lesions and concomitants.
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There are various lesions of the gallbladder that require
surgical intervention. Gallstones and chronic cholecyst-
itis are the most common pathologies, accompanied by
cholesterolosis, adenomatous proliferation of mucous
glands, metaplasia, dysplasia and hyperplasia [1]. Gall-
bladder cancer is the fifth most common malignant neo-
plasm of the gastrointestinal tract [2,3].
Metaplasia, dysplasia and hyperplasia are accepted as
precursor lesions of the gallbladder; however, there is in-
sufficient literature about the relationship of these le-
sions and gallbladder cancer. Detecting these lesions* Correspondence: ozgurtumay@yahoo.com
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reproduction in any medium, provided the orcould provide a better understanding of carcinogenesis,
risk factors and selecting prophylactic cholecystectomy
patients. In this study, we investigated the possibility of
determining increased rates of lesions, particularly pre-
cancerous lesions in gallbladders, which are the most
common surgical material of daily pathology practice,
with increased sample size.Methods
A prospective analysis was conducted at the Pathology
Laboratory, Hatay Antakya State Hospital, and the Path-
ology Department, Mustafa Kemal University, Turkey,
between October 2011 and May 2012, using the records
and materials of laparoscopic cholecystectomies. Thetd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 The distribution of histologic alterations within
the groups
Group 1 (n/%) Group 2 (n/%) P Kappa
Acute cholecystitis 31 (7.2%) 31 (7.2%) >0.05 0.965
Chronic cholecystitis 401 (92.8%) 401 (92.8%)
Non-cholesterolosis 337 (78%) 324 (75%) 0.001 0.904
Cholesterolosis 95 (22%) 108 (25%)
Non-metaplasia 407 (94.2%) 391 (91.2%) 0.0001 0.739
Pyloric metaplasia 23 (5.3%) 38 (8.8%)
Intestinal metaplasia 2 (0.5%) 3 (0.7%)
Non-polyp 422 (97.8%) 416 (96.6%) 0.031 0.76
Cholesterol polyp 7 (1.6%) 11 (2.5%)
Fibroepithelial polyp 1 (0.2%) 2 (0.5%)
Tubular adenoma 1 (0.2%) 1 (0.2%)
Papillary adenoma 1 (0.2%) 1 (0.2%)
Non-dysplasia 430 (99.5%) 430 (99.5%) >0.05 1.0
Low grade dysplasia 2 (0.5%) 2 (0.5%)
High grade dysplasia 0 (0%) 0 (0%)
Carcinoma 0 (0%) 0 (0%) >0.05 1.0
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The histopathologic examination consisted of an initial
macroscopic examination of the specimen and suspi-
cious areas with two or three samples. These specimens
were allocated to Group 1.
The residual specimens were then collected in Mustafa
Kemal University Pathology Department, and the fun-
dus, body and neck of the gallbladders were sampled
randomly. These new six samples with initial ones were
allocated to Group 2.
These samples were then embedded in paraffin, sec-
tioned, stained with hematoxylin and eosin (H&E), and
examined under an Olympus BX53 (Olympus, Tokyo,
Japan) light microscope. In case of existing metaplasia,
the mucin profile was signified histochemically by neu-
tral mucin, periodic acid–Schiff (PAS) Alcian blue
(pH 2.5) and high iron diamine (pH 2.5). All histologic
alterations described on the pathologists’ reports were
included in the study. The presence of acute or chronic
cholecystitis, gallstones, cholesterolosis, pyloric intes-
tinal metaplasia, dysplasia, carcinoma, or polyps was
analyzed as pathological data.Statistical analysis
Statistical evaluations were performed using SPSS 13.0
(IBM, Armonk, NY, USA) for Windows, and P <0.05
was considered statistically significant. For the compari-
son of findings, non-parametric tests, McNemar’s tests,
chi-squared tests and Fisher’s exact test were performed.Results
Of the 432 cases, 308 (71.3%) patients were female and
124 (28.7%) patients were male. Patients’ ages varied
from 18 to 84 years. The mean age of patients was
47.9 ± 14.6 years. Gallstones were obtained in 255 (59%)
cholecystectomies. There were no stones in 177 (41%)
gallbladders. The distributions of histologic alterations are
shown in Table 1. Acute cholecystitis was observed in 31
(7.2%) patients, while chronic cholecystitis was observed in
401 (92.8%) patients in Group 1 and Group 2. There
was no significant difference between them (P >0.05,
kappa = 0.965).
Cholesterolosis was observed in 95 (22%) patients in
Group 1 and 108 (25%) patients in Group 2. There was
a statistically significant difference between both of the
groups (P = 0.001, kappa = 0.904). There were ten polyps
(2.3%) in Group 1: seven (1.6%) were cholesterol
polyps (Figure 1), one (0.2%) was a fibroepithelial
polyp (Figure 2), one (0.2%) was a papillary adenoma,
one (0.2%) was a tubular adenoma (Figure 3), and one
(0.2%) case had both cholesterol and fibroepithelial
polyps.There were 16 (3.2%) polyps in Group 2: 11 (2.5%)
were cholesterol polyps, two (0.5%) were fibroepithelial
polyps, one (0.2%) was a papillary adenoma, one (0.2%)
was a tubular adenoma, and one (0.2%) case had both
cholesterol and fibroepithelial polyps. There was a sta-
tistically significant difference between the two groups
(P = 0.031, kappa = 0.762).
Metaplasia was observed in 25 (5.8%) of the cases in
Group 1: 23 (5.3%) of them were pyloric metaplasia
(Figure 4), while two (0.5%) were intestinal. Forty-one
(9.5%) cases in Group 2 had metaplasia: 38 (8.8%) were
pyloric and three (0.7%) were intestinal. There was a
significant difference between the two groups when
comparing metaplasia (P = 0.0001, kappa = 0.739).
We did not diagnose any carcinoma in this study
period. However, there was mild dysplasia in two (0.5%)
of the cases in both of the groups, and there was no sig-
nificant difference between them (P >0.05, kappa = 1.0).
Discussion
Gallbladder carcinoma is rarely diagnosed in precancer-
ous stages due to its occult evolution and non-specific
symptoms. There is little knowledge about its etiology or
pathogenesis, and determining precursor lesions is dif-
ficult. Environmental and genetic risk factors are im-
portant in carcinoma development. There are two
genetic alterations: adenoma-carcinoma sequence and
the metaplasia-dysplasia-carcinoma sequence [4-6]. Gall-
bladder carcinoma is incidentally discovered during chole-
cystectomies performed for cholelithiasis or cholecystitis.
Diagnosis and sampling of small-sized and flat epithelial
Figure 1 Cholesterol polyp (H&E ×100).
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evaluation of cholecystectomy specimens is important [7].
Pyloric metaplasia is more frequent than intestinal meta-
plasia in cholecystectomies [4,5,8]. We observed pyloric
metaplasia predominance in both of our study groups
with 23 (5.3%) cases in Group 1 and 38 (8.8%) cases in
Group 2, similar to the literature. Metaplastic epithelium
is more susceptible to malignant transformation than the
normal epithelium [9]. We determined low grade dyspla-
sia in two (0.5%) cases, and there was no increase in
the prevalence of this lesion with the increased sampleFigure 2 Fibroepithelial polyp (H&E ×100).size. Besides this observation, there was no significant
relationship between metaplasia and dysplasia. In con-
trast to this study, Mazlum et al. observed metaplasia
in 18 out of 24 dysplastic gallbladders either adjacent
to or within the dysplastic epithelium [10]. Meirelles-
Costa et al. also found an association between pyloric
metaplasia and dysplasia, supporting the metaplasia-
dysplasia-carcinoma sequence [11].
The discrepancies of our results might be related to
the smaller population of our study group and the short
interval of the study. On the other hand, this disease
Figure 3 Tubular adenoma with low grade dysplasia (H&E ×100).
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be planned to obtain results that are similar to the
current literature.
Gallbladder polyps present with conditions differing
from cholesterol polyps to adenomas. Cholesterol polyps
are one of the most frequent types stated in various
studies [10,12,13]. Similar to the literature, we detected
16 (3.2%) polyps in Group 2 with the increased sample
size, and 11 (2.5%) of those were cholesterol polyps. This
variant of polyps is defined as the polypoid form of
cholesterolosis [14]. Cholesterolosis is characterized byFigure 4 Pyloric metaplasia in mucosa (PAS Alcian blue ×100).the accumulation of cholesterol esters in epithelioid his-
tiocytes in the hyperplastic mucosa of the gallbladder
[15]. We found cholesterolosis in 95 (22%) patients in
Group 1 and 108 (25%) patients in Group 2, with a sig-
nificant difference between them. These ratios were
higher when compared to the Mazlum et al. study,
which reported 13.3% of cholesterolosis cases from the
Western part of Turkey [10]. Parallel to our study, Bolat
et al. detected cholesterolosis in 14 (18.7%) patients in
their study [16]. In our geographical area, the population
has a traditional Eastern Mediterranean diet, which is
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bolic syndrome, particularly in women with a higher
body mass index (BMI). We also found more cholesterol
polyps and cholecystitis in females compared to males.
Adenomas are rare lesions of the gallbladder, and can
be identified as tubular, papillary and tubulopapillary
[17]. We observed two (0.4%) adenomas in our study:
one (0.2%) case was tubular and the other (0.2%) papil-
lary. There was low grade dysplasia within the tubular
adenoma, which is described frequently in other studies
[9,17]. However, we did not detect any carcinoma focus
in our cases. This could be related to the rare malignant
transformation and size of the adenoma in gallbladders
when compared to other gastrointestinal organs [18].
On the other hand, we should keep in mind that the de-
velopment of laparoscopic surgical techniques and the
recommendation of cholecystectomy for cholelithiasis
and cholecystitis with long evolution have reduced the
cancer cases [19].
We determined higher ratios of polyp, cholesterolosis
and metaplasia when the sample size was increased in
Group 2. The difference of the results of the two groups
in non-neoplastic lesions might be due to the neglect of
the sampling and evaluation of the lesions. However,
preneoplastic lesions, such as metaplasia and dysplasia,
cannot be determined with macroscopic examination,
and at this point increasing the number of specimens
becomes essential. Parallel to this study, the importance
and value of macroscopic sampling has been highlighted
in other studies [4,5]. Mukhopadhyay et al. also deter-
mined that in most cases of dysplasia with a coexistent
metaplastic lesion, dysplasia arises from precursor le-
sions, not directly from an inflammatory background
[4]. Therefore, sampling of the epithelium, unrelated
with injured and inflamed zones in gallbladders, and
with no mucosal irregularity or thickness for noticing
dysplasia, comes into question. On the other hand, the
detection of focal epithelial changes is a result of the
number of sections examined. Duarte et al. included
fewer patients but used far more extensive sampling.
They found that a single random histologic section
detected less than one third of metaplasias and dyspla-
sias in the gallbladder, and used whole mapping of the
gallbladders in their study [5].
Conclusions
All histologic findings, with the exception of cholelithia-
sis and cholecystitis, had low incidence upon examin-
ation of the cases. However, there was a significant
difference among metaplasia, polyp and cholesterolosis
evaluation between the two groups, suggesting that the
increased sample size would raise the possibility of de-
termining more histologic lesions. Further studies with a
greater number of samples and a longer follow-upperiod might increase the detection of precancerous le-
sions and concomitants.
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